Nitro-oleic acid and epoxy-oleic acid are not altered in obesity and type 2 diabetes

Affiliations

¹ Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany tsikas.dimitros@mh-hannover.de.
² Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

Comment

Dimitrios Tsikas et al. Cardiovasc Res. 2014.

. 2014 Jun 1;102(3):517-8.

doi: 10.1093/cvr/cvu043. Epub 2014 Feb 21.

¹ Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany tsikas.dimitros@mh-hannover.de.
² Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

No abstract available

Comment on

Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity.
Kelley EE, Baust J, Bonacci G, Golin-Bisello F, Devlin JE, St Croix CM, Watkins SC, Gor S, Cantu-Medellin N, Weidert ER, Frisbee JC, Gladwin MT, Champion HC, Freeman BA, Khoo NK. Kelley EE, et al. Cardiovasc Res. 2014 Mar 1;101(3):352-63. doi: 10.1093/cvr/cvt341. Epub 2014 Jan 2. Cardiovasc Res. 2014. PMID: 24385344 Free PMC article.